S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
NASDAQ:CYRX

Cryoport - CYRX Stock Forecast, Price & News

$16.83
-0.83 (-4.70%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$16.80
$17.88
50-Day Range
$15.83
$29.08
52-Week Range
$15.79
$67.88
Volume
288,255 shs
Average Volume
523,214 shs
Market Capitalization
$824.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$40.50

Cryoport MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
140.6% Upside
$40.50 Price Target
Short Interest
Bearish
7.90% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.21mentions of Cryoport in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$142,318 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.88) to ($0.59) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.95 out of 5 stars

Transportation Sector

81st out of 123 stocks

Pharmaceutical Preparations Industry

302nd out of 499 stocks

CYRX stock logo

About Cryoport (NASDAQ:CYRX) Stock

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.

Receive CYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter.

CYRX Stock News Headlines

Cryoport (NASDAQ:CYRX) Price Target Lowered to $30.00 at KeyCorp
Analysts Set Cryoport, Inc. (NASDAQ:CYRX) PT at $42.17
Cryoport Third Quarter 2022 Earnings: Misses Expectations
Cryoport Reports Results for the Third Quarter 2022
Notable Friday Option Activity: AMD, CYRX, SQ
CYRX Crosses Above Key Moving Average Level
See More Headlines
Receive CYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter.

CYRX Company Calendar

Last Earnings
11/04/2021
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/23/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRX
Employees
791
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$40.50
High Stock Price Forecast
$67.00
Low Stock Price Forecast
$28.00
Forecasted Upside/Downside
+140.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-275,530,000.00
Net Margins
-123.41%
Pretax Margin
-123.46%

Debt

Sales & Book Value

Annual Sales
$222.61 million
Book Value
$13.64 per share

Miscellaneous

Free Float
44,247,000
Market Cap
$824.67 million
Optionable
Optionable
Beta
1.21

Key Executives

  • Mr. Jerrell W. SheltonMr. Jerrell W. Shelton (Age 77)
    Chairman, Pres & CEO
    Comp: $1.32M
  • Mr. Robert S. StefanovichMr. Robert S. Stefanovich (Age 57)
    Sr. VP, CFO, Treasurer & Corp. Sec.
    Comp: $683.7k
  • Dr. Mark W. Sawicki Ph.D.
    Sr. VP & Chief Scientific Officer
  • Tony Ippolito
    VP & Gen. Counsel
  • Mr. Thomas J. Heinzen
    VP of Corp. Devel.
  • Mr. Bret Bollinger (Age 55)
    Chief Technology Officer of Cryoport Systems, LLC
  • Mr. Phil Wilson
    Chief Operating Officer of Cryoport Systems, LLC
  • Mr. Raymond Takahashi M.D.
    Exec. Officer
  • Mr. David Petreccia M.D.
    Exec. Officer













CYRX Stock - Frequently Asked Questions

Should I buy or sell Cryoport stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CYRX shares.
View CYRX analyst ratings
or view top-rated stocks.

What is Cryoport's stock price forecast for 2023?

5 analysts have issued 1 year price targets for Cryoport's stock. Their CYRX share price forecasts range from $28.00 to $67.00. On average, they expect the company's share price to reach $40.50 in the next year. This suggests a possible upside of 131.4% from the stock's current price.
View analysts price targets for CYRX
or view top-rated stocks among Wall Street analysts.

How have CYRX shares performed in 2022?

Cryoport's stock was trading at $59.17 at the beginning of 2022. Since then, CYRX shares have decreased by 70.4% and is now trading at $17.50.
View the best growth stocks for 2022 here
.

When is Cryoport's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our CYRX earnings forecast
.

How were Cryoport's earnings last quarter?

Cryoport, Inc. (NASDAQ:CYRX) released its earnings results on Thursday, November, 4th. The consumer goods maker reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.15) by $0.03. The consumer goods maker earned $56.69 million during the quarter, compared to analysts' expectations of $54.44 million. Cryoport had a negative trailing twelve-month return on equity of 14.84% and a negative net margin of 123.41%. The company's revenue was up 407.5% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.29) earnings per share.

What guidance has Cryoport issued on next quarter's earnings?

Cryoport updated its FY 2022 earnings guidance on Thursday, November, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $232.00 million-$238.00 million, compared to the consensus revenue estimate of $260.68 million.

What other stocks do shareholders of Cryoport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Block (SQ).

What is Cryoport's stock symbol?

Cryoport trades on the NASDAQ under the ticker symbol "CYRX."

Who are Cryoport's major shareholders?

Cryoport's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (7.15%), Fred Alger Management LLC (6.24%), BlackRock Inc. (5.95%), Impax Asset Management Group plc (3.49%), Chevy Chase Trust Holdings LLC (3.46%) and Macquarie Group Ltd. (2.83%). Insiders that own company stock include Daniel M Hancock, Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman, Robert J Hariri and Robert Stefanovich.
View institutional ownership trends
.

How do I buy shares of Cryoport?

Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cryoport's stock price today?

One share of CYRX stock can currently be purchased for approximately $17.50.

How much money does Cryoport make?

Cryoport (NASDAQ:CYRX) has a market capitalization of $857.50 million and generates $222.61 million in revenue each year. The consumer goods maker earns $-275,530,000.00 in net income (profit) each year or ($6.15) on an earnings per share basis.

How many employees does Cryoport have?

The company employs 791 workers across the globe.

How can I contact Cryoport?

Cryoport's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The official website for the company is www.cryoport.com. The consumer goods maker can be reached via phone at (949) 470-2300, via email at tfromer@kcsa.com, or via fax at 949-470-2306.

This page (NASDAQ:CYRX) was last updated on 12/9/2022 by MarketBeat.com Staff